Age and Microvascular Function in Patients without Obstructive Coronary Artery Disease

At present, there is increasing interest in the microvascular function of patients with and without obstructive coronary artery disease of different ages. However, these “physiological” effects of age on microvascular function have never been directly quantified on patients without obstructive CAD. Prior studies have focused on patients with angina and obstructive CAD, and the effects on aging. 

Claves para mejorar la productividad en la sala de cateterismo

The aim of this prospective study was to quantitatively investigate the effect of age on microvascular function in patients with normal coronary arteries. 

In 314 patients with angina and no obstructive CAD (ANOCA), microvascular function was assessed using the continuous thermodilution method. In 305 patients, the link between age and both resting and hyperemic myocardial blood flow was assessed, looking at coronary flow reserve (CFR) and microvascular resistance reserve (MRR). Also, patients were divided into three groups according to age quartile (≤52 [24,9%], 53-64 [49,2%], and ≥65 years [25,9%]).

Read also: Invasive Correlation (CFR – IMR) with Coronary Slow Flow.

Mean patient age was 59, and they were mostly women. Mean resting coronary flow showed no significant difference between groups. There was a trend towards reduced mean hyperemic flow (Qmax) as age increased (p=0,083). Resistance increased significantly with age (p=0,005). In consequence, MRR decreased with age (3,2±1,2, 3,1±1,0, 2,9±0,9; p=0,038). This trend was present in patients with (n=121) and without (n=184) coronary microvascular dysfunction (CMD).

Conclusion

There is increased hyperemic microvascular resistance and reduced microvascular function depending on age. This reduction was present in patients with and without microvascular dysfunction, and was particularly apparent in patients without obstructive CAD, which emphasizes the fact that this phenomenon is independent of atherosclerosis. 

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Effects of age on microvascular function in patients with normal coronary arteries.

Reference: Tijn P.J. Jansen MD et al EuroIntervention 2024;20:e690-e698.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...